Merger Notification - Announcement according to § 10 Cartel Act

Cidron Aida Bidco Limited; Advanz Pharma Corporation Limited - BWB/Z-5286 | Bundeswettbewerbsbehörde

Cidron Aida Bidco Limited; Advanz Pharma Corporation Limited

BWB/Z-5286

03.03.2021

On 02.03.2021 the Austrian Federal Competition Authority was notified of the following merger:

Planned purchase process

Cidron Aida Bidco Limited (St Helier/Jersey), an investment vehicle which is indirectly wholly-owned by Nordic Capital Fund X (Luxembourg), intends to acquire all shares in and sole control over Advanz Pharma Corporation Limited, (St Helier/Jersey).

The proposed concentration concerns pharmaceutical products.


Affected industry: Manufacture of pharmaceutical preparations

Industry sector: C - Verarbeitendes Gewerbe/Herstellung von Waren

Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 30.03.2021.

Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.

Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.

Non-prohibition of the merger

The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 31.03.2021 .

back to list